Triamcinolone hexacetonide
In clinical developmentAlso known as Hexatrione, Triamcinolone.
Recent clinical, regulatory, research and industry developments relating to this drug.
Utilization of a Cutaneous Therapy In Situ Microdevice
The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)
Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Utilization of a Cutaneous Therapy In Situ Microdevice
The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- Ophthalmology1
- Aiello LP1
- Antoszyk A1
- Beck R1
- Bressler N1
- Browning D1
- Chew E1
- Danis R1
- Fan J1
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials